Copy number variants (CNVs) are heritable gains and losses of genomic DNA in normal individuals. While copy number variation is widely studied in humans, our knowledge of CNVs in other mammalian species is more limited. We have designed a custom array-based comparative genomic hybridization (aCGH) platform with 385 000 oligonucleotide probes based on the reference genome sequence of the rhesus macaque (Macaca mulatta), the most widely studied non-human primate in biomedical research. We used this platform to identify 123 CNVs among 10 unrelated macaque individuals, with 24% of the CNVs observed in multiple individuals. We found that segmental duplications were significantly enriched at macaque CNV loci. We also observed significant overlap between rhesus macaque and human CNVs, suggesting that certain genomic regions are prone to recurrent CNV formation and instability, even across a total of 50 million years of primate evolution (25 million years in each lineage). Furthermore, for eight of the CNVs that were observed in both humans and macaques, previous human studies have reported a relationship between copy number and gene expression or disease susceptibility. Therefore, the rhesus macaque offers an intriguing, nonhuman primate outbred model organism with which hypotheses concerning the specific functions of phenotypically relevant human CNVs can be tested.
INTRODUCTION
Copy number variants (CNVs) are intra-specific gains or losses of !1 kb of genomic DNA (1, 2) . Recent studies revealed that CNVs are unexpectedly common and frequent among normal human individuals (3 -5) . Furthermore, for many CNVs, copy number is correlated with transcriptional and translational levels (6 -12) , suggesting that CNVs may be involved in phenotypic diversity including differential disease susceptibility. For example, specific CNVs have been identified as risk factors for HIV infection, autoimmune disorders and Crohn's disease, among others (7,9,13 -18) .
However, while CNVs in the human genome have received considerable attention (3 -5,10,12,19 -27) , our understanding of intra-specific CNVs in other mammalian species is substantially more limited, with genome-wide data currently available only for chimpanzees (Pan troglodytes) and mice (Mus musculus) (28 -33) .
Rhesus macaques (Macaca mulatta) are the most widely studied non-human primate for biomedical research (34) , especially in the areas of physiology, behavioral biology, cardiological disorders and infectious disease (35 -38) . For example, rhesus macaques have been indispensable as a model for HIV and AIDS due to their susceptibility to the closely-related (to HIV) simian immunodeficiency virus (SIV) and SIV-HIV-1 chimera (39) , and the first successful primate somatic cell nuclear transfer was recently performed in rhesus macaques (40) . Therefore, identification and characterization of CNVs in the rhesus macaque genome may help us to understand better the relationship between copy number variation and disease. Furthermore, by comparing patterns of intra-specific copy number variation in rhesus macaques to CNVs observed in humans, we may develop a better understanding of the evolutionary forces that shape our genomes. Here, we have performed a study of CNVs in the macaque genome by using a macaque-specific array-based comparative genomic hybridization (aCGH) platform to describe patterns of copy number variation among the genomes of 10 macaque individuals.
RESULTS

CNVs are widespread throughout the rhesus macaque genome
The goal of our study was to characterize levels and patterns of intra-specific copy number variation in rhesus macaques, rather than to identify inter-specific copy number differences among primates (41 -47) . Therefore, we developed a rhesus macaque-specific aCGH platform with 385 000 isothermic oligonucleotide probes roughly evenly spaced throughout the macaque genome (mean distance between probes 6.5 kb). We used this platform to identify CNVs among the genomes of 10 unrelated rhesus macaques (9 individuals each compared with a single rhesus macaque reference individual). Among the 9 test macaques, we identified 132 genomic gains and 82 genomic losses relative to the reference individual, corresponding to 123 distinct CNVs ( Fig. 1 ; Supplementary Material, Table S1 ). Thirty of these CNVs (24%) were observed in multiple individuals.
In order to validate the aCGH results, we first performed real-time quantitative PCR (qPCR) and confirmed 26 out of 27 CNV calls at 7 loci, observing significant correlations between qPCR estimated copy numbers and aCGH log 2 ratios at multiple loci ( Fig. 2 ; Supplementary Material, Table S2 ). Next, we qPCR-genotyped a CNV overlapping the SIGLEC gene family locus in 13 macaque parentoffspring trios (n ¼ 39 individuals). We obtained genotypes that were 100% concordant with Mendelian patterns of inheritance ( Fig. 3) and consistent with Hardy-Weinberg equilibrium (considering parents only; x 2 test; P ¼ 0.671). Although CNVs were found on every chromosome excluding the Y chromosome [which was not sequenced for the current draft of the macaque genome (34) ], the number of CNVs per chromosome was uncorrelated with chromosome length (least squares regression; R 2 ¼ 0.08; P ¼ 0.220). This finding is consistent with previous studies that reported a non-random distribution of CNVs in humans (5, 19) . Furthermore, a large proportion of our CNVs are relatively small (Fig. 4) , near our effective resolution of 40 kb (we used a threshold of six consecutive probes for calling CNVs). In fact, while CNV sizes ranged from 32 to 710 kb, a majority (76%) of the CNVs we identified were ,100 kb in size. For this reason, we infer that our finding of 123 CNVs underestimates the true level of structural variation in the macaque genome, and that a considerable proportion of macaque CNVs could be ,40 kb in size. We did not observe any CNVs .1 Mb in size, which may in part be a consequence of the number and size of sequence gaps in the current draft of the macaque genome sequence (.172 000 gaps, currently estimated at 8% of the genome; 34,48). In addition, previous studies in humans have observed that there are relatively few very large CNVs, and that they tend to be low in frequency (5) , which may explain the absence of these CNVs from our dataset, if the distribution of macaque CNVs is similar. 
Macaque CNVs overlap segmental duplications and human CNVs
CNVs in the human, chimpanzee and mouse genomes are significantly enriched for segmental duplications (3, 5, 19, 30, 33) . Segmental duplications are low-copy repeated sequences of !1 kb with !90% sequence identity (49) that may be involved in CNV genesis through non-allelic homologous recombination (NAHR) mechanisms (reviewed in 50, 51) . Although the segmental duplication content of the macaque genome is less than half that of the human genome (2.3 versus 5.2%; 34,52), we found that 37 of the 123 (30%) macaque CNVs overlapped segmental duplications in the macaque genome, representing a 1.9-fold significant enrichment compared with the level of overlap expected by chance alone ( Fig. 5A ; permutation test; P , 0.0001). Furthermore, of the 30 CNVs observed in multiple macaque individuals, 22 (73%) were found to overlap segmental duplications ( Fig. 5B ; 2.7-fold enrichment; P , 0.0001). These findings suggest that segmental duplication-mediated NAHR plays an important role in the formation of a subset of CNVs across diverse mammalian species, despite substantial differences in genomic segmental duplication content. However, we note the possibility that segmental duplications may be underreported in the current assembly of the rhesus macaque genome sequence (34) . If the known segmental duplication content of the macaque genome does increase, then the proportion of CNVs observed to overlap segmental duplications may also rise. Therefore, these results should be re-examined when subsequent drafts of the macaque genome sequence become available.
We evaluated the overlap between our macaque CNVs and human CNVs that were reported recently for 270 individuals representing four populations from the HapMap collection (5) . Two genome-wide platforms were used in the human study (5) ; because the genome coverage and resolution of our macaque-specific array were similar to those of the large-insert clone whole-genome tile path (WGTP) human platform, we considered only the 867 autosomal CNV calls made by this platform. We unambiguously determined human orthologous positions for 101 of the 123 macaque CNVs. The remaining 22 CNVs were (i) mapped to multiple human chromosomes, (ii) lacked orthologous sequences in the human genome or (iii) had differences in size between the two assemblies that were too great for us to be confident of orthology across the entire region (see Materials and Methods).
We found that 25% (25 of 101) of macaque CNVs are mapped to regions of the human genome previously found to contain CNVs among the 270 HapMap individuals (5), significantly more than expected by chance alone ( Fig. 5C ; 1.8-fold enrichment; P , 0.01). We also observed that CNVs identified in multiple macaques tended to overlap with CNVs identified in multiple humans ( Fig. 5D ; 3.7-fold enrichment; P . 0.001), and we found even greater enrichment when considering human CNVs of !5% frequency (5.6-fold enrichment; P , 0.0001).
DISCUSSION
Mechanisms for CNV formation across mammalian lineages
We have shown that macaque CNVs are enriched for segmental duplications and often occur in regions orthologous to human CNVs. We previously reasoned that CNVs found in the same regions of both humans and chimpanzees likely reflect recurrent CNV formation, rather than ancestral CNVs maintained throughout the evolutionary histories of both species (30) . Given that the human and macaque lineages diverged !25 million years ago (53, 54) , it is even more likely that CNVs in orthologous regions in both macaques and humans were formed by independent events. However, while segmental duplications present in the humanchimpanzee common ancestor may have maintained 99% sequence similarity among paralogous copies within a given species (43) and therefore may facilitate NAHR in both species (30) , genome-wide human -macaque nucleotide sequence divergence is 7% (34). While rare NAHR events can be mediated by perfectly matching segments smaller than 50 bp in size (55), more common NAHR events may require perfectly matching segments of .300 bp in length (56) , and NAHR most frequently occurs between duplications .10 kb with .95% sequence similarity to each other (51) . This level of required sequence similarity is greater than the similarity that may be expected for paralogous copies of segmental duplications that were present in the genome of the human -macaque common ancestor (i.e. 93%). Therefore, one might expect reduced levels of NAHR for older segmental duplications, which could implicate mechanisms other than NAHR in frequent and recurrent CNV formation in the same genomic regions of both macaques and humans.
To examine this issue, we assessed the segmental duplication content of the CNVs observed in orthologous regions of macaques and humans, and found that 52% of these CNVs (13 of 25) in fact contain segmental duplications in both genomes. One explanation for this observation could be that new segmental duplications have formed in similar regions of both genomes following their divergence (i.e. segmental duplications in these regions were not actually present in the macaque -human ancestor). However, we consider several other (and non-mutually exclusive) explanations to be more likely. First, due to stochastic mutation patterns, stretches of .95% sequence similarity that are sufficiently large for NAHR (including perfectly matching segments hundreds of bp in length) may have been maintained between segmental duplication paralogs, even over !25 million years. Second, gene conversion may have homogenized ancestral segmental duplications (57, 58) , potentially preserving higher than expected within-species sequence identity in both lineages. For example, this process has been linked to the long-term maintenance of a structural rearrangement hot spot in eutherian mammals, mediated by segmental duplications that arose .100 million years ago (59) . To explore this possibility further, we estimated the sequence divergence and phylogenies of segmental duplication paralogs and orthologs within or flanking a subset of the CNV regions in macaques and humans. In each case, we observed that nucleotide sequence divergence among duplicons was .7% across species but 5% within species (Supplementary Material, Fig. S1 ), consistent with a model of recurrent gene conversion in both lineages. In addition, these regions may have been unstable throughout the evolutionary histories of both species, with recurrent copy number gains providing substrates for further CNV genesis (60) . Together, these forces may effectively maintain CNV hot spots across a surprising diversity of mammalian lineages.
Evaluating the functional relevance of macaque CNVs
Initial reports of associations between copy number and gene expression levels (6, 10, 12) and copy number and susceptibility to complex diseases (e.g. refs. 7,14,17) in humans have prompted speculation that copy number variation may play a considerable role in phenotypic diversity (1, 61) . However, our knowledge of the functional consequences of even the few thoroughly studied human CNVs remains limited. Among the macaque CNVs identified in our study, eight mapped to genomic regions containing human CNVs that have been implicated in disease susceptibility or correlated with gene expression levels (Table 1) , representing an intriguing opportunity for model organism studies of functionally relevant human CNVs.
For example, we observed multiple gains and losses at the macaque b-defensin gene cluster locus, including the DEFB4 gene. Copy number variation of this gene in humans has been associated with susceptibility to Crohn's disease, a chronic inflammation of the gastrointestinal tract (9) . Given the possible genetic and microbial influences on Crohn's disease (62, 63) and the bactericidal roles of the b-defensins (64), the rhesus macaque may be an appropriate model organism for investigating the potential correlation between b-defensin gene dosage and microbiotic composition. Ultimately, the efficacy of targeted antibacterial drugs could be tested on macaques with different backgrounds of b-defensin copy number in pharmacogenomics-based studies.
In addition, we detected multiple copy number losses overlapping the cytochrome P450, family 2, subfamily A locus, which is also copy number variable in humans (5, 10, 65) . One member of this gene family is CYP2A6, which is responsible for the metabolism of nicotine and the activation of procarcinogens found in tobacco smoke (66, 67) . Previous studies in humans have shown that duplications and deletions at this locus are generated by NAHR (68, 69) , and that the deletion allele may confer protection against lung cancer (13, 70, 71) . In macaques, the effects of copy number changes on in vivo enzymatic activities of CYP2A subfamily genes could be assessed to understand better the relationship between nicotine metabolism and cancer and addiction behavior. For example, levels of metabolized nicotine could be measured across individuals with different copy numbers. A similar approach could be used to investigate CYP-mediated activation of procarcinogens and subsequent oncogenesis. Finally, rhesus macaque studies could be informative with regard to any CNV-related effects on CYP-inhibiting drug response (reviewed in 72, 73) .
The examples discussed above and presented in Table 1 are based on the limited number of studies that have investigated the functional effects of human CNVs. More human CNVs that are orthologous to the observed macaque CNVs may later be found to be associated with specific human phenotypes, for example, through future genome-wide CNV disease association studies (74) . Furthermore, additional Table S1 ) should also be considered to be of potential functional significance, for example the CNV encompassing the UGT2B7 gene. Single-nucleotide polymorphisms in human UGT2B7 have been implicated in differential drug and hormone responses (83) (84) (85) , and deletion variants in another member of the UGT2 family have been associated with prostate cancer in humans (16) .
f
The endpoint coordinates for this locus are .5 times larger in the human reference genome sequence compared to the macaque reference genome (see Materials and Methods) due to large segmental duplications and a gap in the human sequence; however, we established that the nucleotide sequence of the macaque CNV region aligns to the human b-defensin locus, including the DEFB4 gene.
macaque CNVs will undoubtedly be identified with the application of higher resolution platforms and larger population samples; a proportion of these CNVs may also be orthologous to functionally relevant human CNVs.
Conclusion
We have identified 123 CNVs among the genomes of 10 rhesus macaque individuals. To our knowledge, this is the first successful attempt to map copy number variation in rhesus macaques at a genome-wide level. Our analyses have shown that a surprising number of CNVs are mapped to genomic regions that are also copy number variable in humans. These findings have two immediate implications for the medical and evolutionary genetics communities: (i) future rhesus macaque-based biomedical research studies may benefit from fully accounting for copy number variation and any subsequent gene dosage effects, and (ii) the macaque is an ideal model organism for testing hypotheses concerning the functional significance of CNVs, including for many CNV loci that are directly relevant to human disease.
MATERIALS AND METHODS
Sample preparation
Whole venous blood was collected from 4 male and 6 female unrelated (with known ancestry for a minimum of three generations), outbred rhesus macaques and 13 parent -offspring trios during routine health evaluations at the New England Primate Research Center. All individuals were descendants from Indian-origin rhesus macaques. DNA was isolated from peripheral leukoctyes with the Puregene DNA isolation kit (Gentra, Minneapolis, MN) and purified using the Wizard DNA Cleanup System (Promega, Madison, WI).
Custom array design
Human -macaque nucleotide sequence divergence is 7% (ref. 34) , which could result in hybridization specificity and efficiency issues if macaque samples were used with humanspecific arrays (75) . Furthermore, with a human-specific array we would not be able to examine regions present in the rhesus macaque but not the human genome (i.e. human lineage-specific deletions). Therefore, we designed a high density (385 000 probes) oligonucleotide aCGH platform based on the rhesus macaque genome assembly (Mmu1_051212; rheMac2; January 2006) by NimbleGen Systems Inc. (design 2006-11-30_rheMac2_WG_CGH). We favored a genome-wide over a gene-focused approach because previous studies have shown that a subset of intergenic CNVs may be functionally relevant, for example, by influencing expression levels of nearby genes (12) . In addition, full genomic coverage lets us make more precise inferences regarding the sizes of identified CNVs. Therefore, probes were distributed as evenly as possible throughout the genome, with mean probe spacing of 6.5 kb. We excluded sequences with .5 identical matches elsewhere in the genome from the array (i.e. to avoid placing probes in recently transposed copies of highly-repetitive sequences such as Alu elements), but included segmental duplications. Probe length varied between 50-75 nucleotides with target melting temperatures of 768C. The arrays were printed at the NimbleGen facility in Reykjavik, Iceland.
aCGH experiments
DNA samples for test individuals were labeled with Cy5 and co-hybridized onto our platform with Cy3-labeled DNA from a single female reference individual (mmu 313_2000).
We also performed two self-self hybridization experiments (i.e. by labeling DNA from a single individual separately with Cy3 and Cy5 and co-hybridizing both labeled samples to an array); one using DNA from the female reference individual, and another with DNA from one of the male test individuals (mmu 211_1999). Each self-self experiment was performed with two aliquots from a single DNA extraction. All experiments were labeled and hybridized using standard NimbleGen aCGH protocols in Reykjavik, Iceland. Briefly, 1 mg of genomic DNA was labeled with random 9-mer 'wobble'-Cy3 or Cy5 (TriLink BioTechnologies, San Diego, CA) using Exo-Klenow DNA polymerase (New England Biolabs, Ipswich, MA), at 378C for 2 h. Hybridization was performed using the MAUI Hybridization System (BioMicro Systems, Salt Lake City, UT) at 428C for 16 h. Arrays were scanned with a GenePix 4000B 5 mm microarray scanner (Axon Instruments, Foster City, CA). Signal intensities were extracted using NimbleScan software (NimbleGen Systems, Inc.), and relative intensity log 2 ratios were normalized using the Qspline method (76) . All normalized Cy-3/Cy-5 intensity data from the aCGH experiments have been deposited to the Gene Expression Omnibus database (accession number GSE9220). All sample-level CNV calls with corresponding log 2 values are provided in Supplementary Material, Table S3 .
CNV analyses
CNVs were identified based on the relative intensity log 2 ratio profiles of each experiment, using the BreakPtr algorithm (77) . Following the protocol of Korbel et al. (77) , we generated CNV calls with a hidden Markov model by using positive and negative training parameters based on log 2 ratio data. Positive controls (i.e. 'gold standards') consisted of 16 putative copy number gains and losses that were validated by qPCR (Supplementary Material, Table S4 ), whereas negative controls consisted of log 2 data from one self-self hybridization experiment (mmu 211_1999). We then set the minimum number of probes required for a CNV call by comparing the number of calls for the nine test experiments with the number of (false-positive) calls from the second self-self experiment (mmu 313_2000) while varying the minimum number of probes required for calling a CNV (Supplementary Material, Fig. S2 ). We found that a 3-probe threshold was sufficient to eliminate CNV calls on the self-self experiment. However, as the single self-self hybridization experiment cannot fully reflect the variance of our nine test experiments and because we preferred a low false-positive rate even at the expense of having more false negatives in our dataset, we established a more conservative threshold of 6 probes for CNV calls (resulting in an effective resolution of 40 kb). We noted that our platform and CNV calling parameters detected gains and losses at the major histocompatibility complex locus on macaque chromosome 4, consistent with previous studies (78, 79) . One CNV was identified on the X chromosome in one female individual (Supplementary Material, Table S1), which was excluded from subsequent analysis because we could not reliably call X chromosome CNVs for male test individuals (versus the female reference). All CNV calls with a probe density of ,1 probe per 50 kb were examined and reanalyzed as separate regions if they contained intervening assembly gaps. This affected five CNVs in the final dataset. CNV calls from different individuals that overlapped one another were merged and treated as a single CNV in our analyses.
Enrichment analyses were performed using a permutation test of 10 000 randomized trials. For evaluating segmental duplication enrichment, macaque genome autosomal segmental duplication coordinates (rheMac2) were downloaded from the UCSC Genome Browser (34, 48) . The locations of the macaque CNVs were randomized based on the midpoint coordinates of all autosomal oligonucleotide probes on our platform (the sizes of the randomized CNVs were identical to the actual observed CNV sizes). For each trial, the number of randomized CNVs that overlapped (defined as !1 bp in common) with macaque segmental duplications was determined. To test for enrichment, we compared the observed number of CNVs that overlapped with segmental duplications based on the actual locations of the macaque CNVs, to the distribution from the permutation analysis.
To determine whether macaque and human CNVs occur in orthologous regions more often than expected by chance, we first converted the positions of the macaque CNVs to orthologous human coordinates (hg17) using the Batch Coordinate Conversion (liftOver) tool from the UCSC Genome Bioinformatics resource (80) . This was accomplished by obtaining liftOver coordinates for 1 kb of sequence flanking each putative breakpoint of all CNV calls (2 kb for each CNV end) and combining these results. Thirty-one macaque CNV breakpoint sequences that were duplicated in the human genome were converted manually using the Convert tool of the UCSC Genome Browser (80) . Using these two approaches, human orthologous positions were obtained for 101 of the 123 macaque CNVs (Supplementary Material, Table S1 ). The remaining 22 macaque CNVs had putative breakpoints that mapped to multiple human chromosomes (n ¼ 7), were mapped to the human X chromosome (which was not included in our analysis; n ¼ 1), lacked orthologous sequences in the human genome (n ¼ 11), or were excluded because the human converted genomic region size differed by .5-fold from the macaque CNV size and we could not be confident of orthology across the entire region (n ¼ 3). We then performed permutation analyses with 10 000 trials, as described above for segmental duplications, except that we used a database of human CNVs from the WGTP aCGH platform, previously used to identify CNVs in 270 HapMap individuals (5) , and randomized the location of these CNVs based on the midpoint positions of all autosomal clones on the WGTP array, because it was not practical to convert the coordinates of all the human CNVs to the macaque genome. For each trial, we then determined the number of macaque CNVs that overlapped the human CNVs and compared this distribution to the observed number of macaque CNVs that overlapped the human CNVs based on their actual locations.
Quantitative PCR
Specific primers were designed from the rheMac2 reference genome sequence, for both the putative copy number variable regions of interest and an endogenous control locus (PAX9). A 5-point standard curve (0.5 -8 ng of DNA) was generated in duplicate for a single reference individual, while test individuals were assayed in triplicate using 2 ng of DNA per reaction. iQ SYBR Green Supermix and the iQ5 detection system (Bio-Rad Laboratories, Hercules, CA) were used for nucleic acid detection. Reactions were performed at 958C for 3 min followed by 40 cycles of 958C for 10 s and 608C for 30 s. Mean DNA starting quantities and standard deviations were estimated based on threshold cycle differences between the control and test loci. Primer sequences are available in Supplementary Material, Table S4 .
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
